Global Infertility Drug Pipeline Analysis


Naperville, IL -- (SBWIRE) -- 06/02/2014 -- Reportstack, provider of premium market research reports announces the addition of Global Infertility Drug Pipeline Analysis market report to its offering
The market for reproductive medicine is experiencing a paradigm shift with new latest techniques being used and awareness among people increasing due to imparting knowledge about these techniques. The infertility drugs market promises significant room for growth. The market has high potential to scale up in order to meet the needs of infertile couples and also due to growth in reproductive tourism. Venture capitalists have entered the market by investing huge amounts in setting up chains of infertility clinics, which provide drugs and treatment. The most lucrative markets for infertility drugs are the emerging nations such as India, Brazil, China and Mexico, where the population is huge and there exist large pool of people being affected by lifestyle diseases, thus leading to infertility.

Global Infertility Drug Pipeline Analysis by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of infertility. Research report covers all the ongoing drugs being developed in various development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the infertility treatment drug market based upon development process.

Following parameters for each drug profile in development phase are covered in Global Infertility Drug Pipeline Analysis research report:

Drug Profile Overview

Alternate Names for Drug

Active Indication

Phase of Development

Mechanism of Action

Brand Name

Patent Information

Orphan Designation by Indication, Country & Organisation

Country for Clinical Trial

Owner / Originator/ Licensee/Collaborator

Administrative Route

Drug Class

ATC Codes

Infertility Drug Pipeline by Clinical Phase:

Research: 1

Preclinical: 12

Phase-I: 2

Phase-II: 7

Phase-III: 8

Preregistration: 1

Marketed: 19

To view the table of contents for this market research report please visit
Roger Campbell
United States
Ph: 888-789-6604